Your browser doesn't support javascript.
loading
Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State.
Müller, Nicola F; Wagner, Cassia; Frazar, Chris D; Roychoudhury, Pavitra; Lee, Jover; Moncla, Louise H; Pelle, Benjamin; Richardson, Matthew; Ryke, Erica; Xie, Hong; Shrestha, Lasata; Addetia, Amin; Rachleff, Victoria M; Lieberman, Nicole A P; Huang, Meei-Li; Gautom, Romesh; Melly, Geoff; Hiatt, Brian; Dykema, Philip; Adler, Amanda; Brandstetter, Elisabeth; Han, Peter D; Fay, Kairsten; Ilcisin, Misja; Lacombe, Kirsten; Sibley, Thomas R; Truong, Melissa; Wolf, Caitlin R; Boeckh, Michael; Englund, Janet A; Famulare, Michael; Lutz, Barry R; Rieder, Mark J; Thompson, Matthew; Duchin, Jeffrey S; Starita, Lea M; Chu, Helen Y; Shendure, Jay; Jerome, Keith R; Lindquist, Scott; Greninger, Alexander L; Nickerson, Deborah A; Bedford, Trevor.
Affiliation
  • Müller NF; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. nicola.felix.mueller@gmail.com tbedford@fredhutch.org.
  • Wagner C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Frazar CD; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Roychoudhury P; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Lee J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Moncla LH; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Pelle B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Richardson M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Ryke E; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Xie H; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Shrestha L; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Addetia A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Rachleff VM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Lieberman NAP; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Huang ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Gautom R; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Melly G; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Hiatt B; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
  • Dykema P; Washington State Department of Health, Shoreline, WA 98155, USA.
  • Adler A; Washington State Department of Health, Shoreline, WA 98155, USA.
  • Brandstetter E; Washington State Department of Health, Shoreline, WA 98155, USA.
  • Han PD; Washington State Department of Health, Shoreline, WA 98155, USA.
  • Fay K; Seattle Children's Research Institute, Seattle, WA 98101, USA.
  • Ilcisin M; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  • Lacombe K; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Sibley TR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Truong M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Wolf CR; Seattle Children's Research Institute, Seattle, WA 98101, USA.
  • Boeckh M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Englund JA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Famulare M; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  • Lutz BR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Rieder MJ; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  • Thompson M; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
  • Duchin JS; Seattle Children's Research Institute, Seattle, WA 98101, USA.
  • Starita LM; Department of Pediatrics, University of Washington, Seattle, WA 98105, USA.
  • Chu HY; Institute for Disease Modeling, Bellevue, WA 98105, USA.
  • Shendure J; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
  • Jerome KR; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.
  • Lindquist S; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
  • Greninger AL; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
  • Nickerson DA; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  • Bedford T; Public Health - Seattle & King County, Seattle, WA98121, USA.
Sci Transl Med ; 13(595)2021 05 26.
Article in En | MEDLINE | ID: mdl-33941621
ABSTRACT
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has gravely affected societies around the world. Outbreaks in different parts of the globe have been shaped by repeated introductions of new viral lineages and subsequent local transmission of those lineages. Here, we sequenced 3940 SARS-CoV-2 viral genomes from Washington State (USA) to characterize how the spread of SARS-CoV-2 in Washington State in early 2020 was shaped by differences in timing of mitigation strategies across counties and by repeated introductions of viral lineages into the state. In addition, we show that the increase in frequency of a potentially more transmissible viral variant (614G) over time can potentially be explained by regional mobility differences and multiple introductions of 614G but not the other variant (614D) into the state. At an individual level, we observed evidence of higher viral loads in patients infected with the 614G variant. However, using clinical records data, we did not find any evidence that the 614G variant affects clinical severity or patient outcomes. Overall, this suggests that with regard to D614G, the behavior of individuals has been more important in shaping the course of the pandemic in Washington State than this variant of the virus.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genome, Viral / SARS-CoV-2 / COVID-19 Limits: Humans Country/Region as subject: America do norte Language: En Journal: Sci Transl Med Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genome, Viral / SARS-CoV-2 / COVID-19 Limits: Humans Country/Region as subject: America do norte Language: En Journal: Sci Transl Med Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article